Synedica Retatrutide 40mg

Retatrutide 40 mg is an investigational peptide compound currently being studied for its activity as a multi-receptor agonist targeting GLP-1, GIP, and glucagon pathways. Designed for research and scientific evaluation, retatrutide has generated interest in metabolic and endocrinology research settings due to its novel mechanism of action.

Each unit contains 40 mg of retatrutide and is intended for laboratory, analytical, or research applications where permitted.

Key Features

• 40 mg retatrutide per unit
• Investigational triple-hormone receptor activity (GLP-1, GIP, glucagon)
• Intended for research and scientific use only